Subtle signs of neurodegeneration can be detected in blood, CSF, and neuroimaging, up to 20 years before the motor symptoms ...
The FDA agreed that the reported data from the ongoing early to mid-stage studies of AMT-130 for Huntington’s disease compared ... PFE shares have lost 12.4% in the past three months.
its candidate for an inherited neurological condition called Huntington’s Disease, failed in a mid-stage trial. The 12-week DIMENSION study evaluated how dalzanemdor, also known as SAGE-718 ...
In a recent conference call, Huntington Bancshares announced its fourth-quarter (Q4) results, showcasing a remarkable ...